Chemoinformaics analysis of Regholarrhenine D
Molecular Weight | 358.57 | nRot | 1 |
Heavy Atom Molecular Weight | 320.266 | nRig | 24 |
Exact Molecular Weight | 358.298 | nRing | 5 |
Solubility: LogS | -3.472 | nHRing | 1 |
Solubility: LogP | 4.219 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 66.7501 |
nHD | 1 | BPOL | 40.4019 |
QED | 0.696 |
Synth | 5.157 |
Natural Product Likeliness | 2.157 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.002 |
HIA | 0.017 |
CACO-2 | -4.83 |
MDCK | 0.00000479 |
BBB | 0.886 |
PPB | 0.663859 |
VDSS | 1.37 |
FU | 0.306514 |
CYP1A2-inh | 0.035 |
CYP1A2-sub | 0.511 |
CYP2c19-inh | 0.031 |
CYP2c19-sub | 0.987 |
CYP2c9-inh | 0.053 |
CYP2c9-sub | 0.139 |
CYP2d6-inh | 0.942 |
CYP2d6-sub | 0.925 |
CYP3a4-inh | 0.102 |
CYP3a4-sub | 0.869 |
CL | 18.253 |
T12 | 0.032 |
hERG | 0.131 |
Ames | 0.02 |
ROA | 0.115 |
SkinSen | 0.015 |
Carcinogencity | 0.414 |
EI | 0.008 |
Respiratory | 0.981 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.710103 |